1. Epigenome-wide association studies: the exposures of yesterday form the methylations of tomorrow
    Markus Weckmann et al, 2023, European Respiratory Journal CrossRef
  2. Moderate exercise combined with metformin-treatment improves mitochondrial bioenergetics of the quadriceps muscle of old female Wistar rats
    Stefanie Paola López-Cervantes et al, 2022, Archives of Gerontology and Geriatrics CrossRef
  3. Ferulic acid attenuates high glucose-induced MAM alterations via PACS2/IP3R2/FUNDC1/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats
    P. Salin Raj et al, 2023, International Journal of Cardiology CrossRef
  4. Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
    Teresa Salvatore et al, 2021, Biomolecules CrossRef
  5. Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells in vitro
    Kasja Pavlovic et al, 2022, Frontiers in Pharmacology CrossRef
  6. Metformin suppresses cardiac fibroblast proliferation under high-glucose conditions via regulating the mitochondrial complex I protein Grim-19 involved in the Sirt1/Stat3 signaling pathway
    Yongguang Li et al, 2023, Free Radical Biology and Medicine CrossRef
  7. AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine
    Changxing Liu et al, 2023, Journal of Inflammation Research CrossRef
  8. Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients
    Ana Lascu et al, 2022, Life CrossRef
  9. Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs
    Yutong Zhou et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  10. Therapeutic Potential of Metformin in Diabetes Mellitus-Related Cardiovascular Complications
    Hongmei Tan et al, 2023, Metformin - A Prospective Alternative for the Treatment of Chronic Diseases CrossRef
  11. Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies
    Dexiang Xia et al, 2023, The American Journal of Pathology CrossRef
  12. The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy
    Li-Chan Tao et al, 2022, Biomolecules & Therapeutics CrossRef
  13. Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells
    Shanshan Gou et al, 2021, Toxicology and Applied Pharmacology CrossRef
  14. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments
    Fumin Zhi et al, 2023, Cell Stress and Chaperones CrossRef
  15. Leydig cell development in pubertal male rats is blocked by perfluorotetradecanoic acid through decreasing AMPK-mTOR-autophagy pathway
    Yunbing Tang et al, 2023, Toxicology Letters CrossRef
  16. Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications
    Jin Feng et al, 2022, Pharmacological Research CrossRef
  17. Novel insights into the whole-blood DNA methylome of asthma in ethnically diverse children and youth
    Esther Herrera-Luis et al, 2023, European Respiratory Journal CrossRef
  18. Three-Dimensional Stretchable Sensor-Hydrogel Integrated Platform for Cardiomyocyte Culture and Mechanotransduction Monitoring
    Ming Chen et al, 2023, Analytical Chemistry CrossRef